We have previously shown in rats that lipopolysaccharide (LPS) causes both decreased renal perfusion and kidney arginine production before nitric oxide (NO) synthesis, resulting in a Ͼ30% reduction in plasma arginine. To clarify the early phase effects of LPS, we asked the following two questions: 1) is the rapid change in renal arginine production after LPS simply the result of decreased substrate (i.e., citrulline) delivery to the kidney or due to impaired uptake and conversion and 2) is the systemic production of NO limited by plasma arginine availability after LPS? Arterial and renal vein plasma was sampled at 30-min intervals from anesthetized rats with or without citrulline or arginine (2 mol ⅐ min Ϫ1 ⅐ kg Ϫ1 iv) a dose with no effect on MAP, renal function, or NO production. Exogenous citrulline was quickly converted to arginine by the kidney, resulting in plasma levels similar to equimolar arginine infusion. Also, the increase in citrulline uptake resulted primarily from increased filtered load and reabsorption. In a separate series, citrulline was infused after LPS administration, verifying that citrulline uptake and conversion persists during impaired kidney function. Last, in rats given LPS, the elevation of plasma arginine had no discernable impact on mean arterial pressure, kidney function, or systemic NO production. This work demonstrates how arginine synthesis is normally "substrate limited" and explains how impaired kidney perfusion quickly results in decreased plasma arginine. However, contrary to in vitro studies, the significant reduction in extracellular arginine during the early phase response to LPS in vivo is not functionally rate limiting for NO production.citrulline; arginase; argininosuccinate; high-performance liquid chromatography ARGININE ABSORBED BY THE GUT is largely converted to citrulline before entering the circulation or is taken up by the liver from the portal circulation, generating ornithine and urea (13,28,35). Extracellular arginine primarily originates from the kidney, which, in turn, depends on the uptake and conversion of citrulline from plasma (7,8,(12)(13)(14)32). Estimates based on renal production and plasma concentration indicate that the turnover rate for extracellular arginine is ϳ40 min (23). Arginine is the precursor to nitric oxide (NO) via the action of at least three isoforms of nitric oxide synthase (NOS), and expression of the inducible isoform (iNOS) results in large-scale NO release (1). Experimentally, iNOS can be induced in vitro with cytokines and in vivo with lipopolysaccharide (LPS) of bacterial origin. Large-scale production of antiseptic NO is part of the innate immune response; however, overproduction may exhaust tonic maintenance of vascular tone, inhibit mitochondrial respiration, and directly modify regulatory proteins (1,16,20,25,27,31,36).In previous studies, we showed that the LPS-induced changes in kidney arginine production occurred at a time and were of a sufficient magnitude to fully account for decreased plasma content (23). In fact, t...